<unk>  () (developmental code names EM-652, SCH-57068) is a nonsteroidal selective estrogen receptor modulator (SERM) which, as of 2015, is in phase III clinical trials for the treatment of breast cancer.
Acolbifene
Ospemifene
Toremifene
Tiotixene
Mitapivat
Veristrat
Sesquimustard
Stiripentol